Blog
66% of community pharmacists have experienced abuse
66% of community pharmacists have admitted to experiencing forms of abuse from the public, being over worked, burnt out, suffering from poor mental health and not getting sufficient breaks and protected time for learning as found by the Royal Pharmaceutical Society’s (RPS) workforce wellbeing survey.
Update GMP and GDP Certificates
Anyone who has recently reviewed the Medicines and Healthcare products Regulatory Agency (MHRA) CMS may have noticed the notification at the bottom of the search page regarding GMP and GDP Certificates, stating the following
Serious Shortage Protocols (SSPs)
UK Pharmacists and Pharmacies have received communication for the Royal Pharmaceutical Society yesterday (15th December 2022) regarding the addition of 3 penicillin products to the list of products impacted by serious shortages in supply.
NIMAR – The list was updated 21.12.2022
The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market
Antibiotics supply issue
Previously this year we saw a shortage of HRT medication and now pharmacies are facing shortages of common antibiotics such as Amoxicillin.
Pharmacy First to solve GP appointment crisis
Steve Barclay, health secretary has suggested that the ‘Pharmacy First’ model is the solution to help alleviate pressure from GP’s and free up more appointments.
Striking for Pharmacists not an option?
With threats of strikes happening all over the healthcare sector and even you local postie, why is that you never hear of pharmacists striking?
MHRA Guidance Note 6
MHRA Guidance Note 6 – Notes for applicants and holders of a Wholesale Dealer’s Licence (WDA(H)) or Broker Registration was updated in November 2022 with some significant changes regarding Brexit.
Patient Complaints against GP Pharmacists increase by 48% in one year
2253 patient complaints were made against pharmacists working in GP practices in the year ending March 2022 compared to 1521 the previous year. This, according to figures recently published by NHS Digital.
Unlicensed Cannabis-Based Products for Medicinal (CBPM) Use
On the 16th of November 2022 the Medicines and Healthcare products Regulatory Agency (MHRA) released a blog with guidance on the process for approving Manufacturing Authorisations/ API Registrations in relation to unlicensed Cannabis-Based Products for Medicinal (CBPM) use.
NIMAR – The list is getting longer…
The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market
The value of proper Export training – be prepared!
Many clients contact us for information and help on expanding the scope of their WDA license to include the ability to export UK licensed medicinal products without necessarily understanding the challenges of exporting UK licensed medicinal products.